Author Archive: AZBio
Accelerate Diagnostics Achieves CE-IVD Milestone and Expands Preclinical Study
Accelerate Diagnostics Achieves CE-IVD Milestone for ID/AST System and ID/AST Blood Culture AssayContinue reading
AMAG Pharmaceuticals to Acquire CBR for $700M
NuvOx Pharma Files Patent Application with University of Pittsburgh in Sickle Cell Disease
NuvOx Pharma has completed a licensing agreement with the University of Pittsburgh for a patent application entitled, “Treatment of Acute Complications of Sickle Cell Disease.”Continue reading
RCT leads $11.5 M Funding Round for Cymedica Orthopedics of Scottsdale
CYMEDICA ORTHOPEDICS ANNOUNCES $11.5 MM SERIES A FUNDING ROUNDContinue reading
New Phase Ib/II clinical trial using a new immunotherapy treatment begins at CTCA
Cancer Treatment Centers of America® (CTCA) at Western Regional Medical Center (Western) in Goodyear, Arizona, has begun a new Phase Ib/II clinical trial using a new immunotherapy treatment for patients with advanced kidney, non-small cell lung cancer, pancreatic cancer and colorectal carcinoma.Continue reading
C-Path Leadership Team Expanding with Three New Board Members
CRITICAL PATH INSTITUTE ANNOUNCES APPOINTMENTS OF PETER HUTT, ALAN LEVIN, AND PAULA OLSIEWSKI TO ITS BOARD OF DIRECTORSContinue reading
Paradigm Announces Partnership with Cure Forward to Power Novel Social Data Platform
Paradigm and Cure Forward announced a partnership on June 18,2015 under which Paradigm will serve as a core diagnostic laboratory partner (DLP) for the provision of Next-Generation Sequencing (NGS)-based molecular profiling for cancer patients.Continue reading